Amneal clears five FDA supplements: REMS update on buprenorphine/naloxone leads weekAug 14Weekly roundup, 5 itemsAmneal Pharmaceuticals, LLCbuprenorphine
PolyPid's D-PLEX100 NDA accepted with priority review, PDUFA date set for November 2026Jul 29Regulatory milestonePolyPid Ltd
Sign inSign in